Cargando…

What’s new in dry eye disease diagnosis? Current advances and challenges

Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Shruti, Galor, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305205/
https://www.ncbi.nlm.nih.gov/pubmed/30613376
http://dx.doi.org/10.12688/f1000research.16468.1
_version_ 1783382513951965184
author Aggarwal, Shruti
Galor, Anat
author_facet Aggarwal, Shruti
Galor, Anat
author_sort Aggarwal, Shruti
collection PubMed
description Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents an umbrella term that encompasses many different underlying conditions and pathophysiological mechanisms. The purpose of this article is to highlight aspects of DED pathophysiology and focus on targeted diagnostic and therapeutic approaches to this multifactorial, chronic condition.
format Online
Article
Text
id pubmed-6305205
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-63052052019-01-03 What’s new in dry eye disease diagnosis? Current advances and challenges Aggarwal, Shruti Galor, Anat F1000Res Review Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents an umbrella term that encompasses many different underlying conditions and pathophysiological mechanisms. The purpose of this article is to highlight aspects of DED pathophysiology and focus on targeted diagnostic and therapeutic approaches to this multifactorial, chronic condition. F1000 Research Limited 2018-12-19 /pmc/articles/PMC6305205/ /pubmed/30613376 http://dx.doi.org/10.12688/f1000research.16468.1 Text en Copyright: © 2018 Aggarwal S and Galor A http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Aggarwal, Shruti
Galor, Anat
What’s new in dry eye disease diagnosis? Current advances and challenges
title What’s new in dry eye disease diagnosis? Current advances and challenges
title_full What’s new in dry eye disease diagnosis? Current advances and challenges
title_fullStr What’s new in dry eye disease diagnosis? Current advances and challenges
title_full_unstemmed What’s new in dry eye disease diagnosis? Current advances and challenges
title_short What’s new in dry eye disease diagnosis? Current advances and challenges
title_sort what’s new in dry eye disease diagnosis? current advances and challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305205/
https://www.ncbi.nlm.nih.gov/pubmed/30613376
http://dx.doi.org/10.12688/f1000research.16468.1
work_keys_str_mv AT aggarwalshruti whatsnewindryeyediseasediagnosiscurrentadvancesandchallenges
AT galoranat whatsnewindryeyediseasediagnosiscurrentadvancesandchallenges